School Deworming at a Glance
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
A Call to Support Francophone African
KNOWLEDGE BRIEF Health, Nutrition and Population Global Practice A CALL TO SUPPORT FRANCOPHONE Public Disclosure Authorized AFRICAN COUNTRIES TO END THE TREMENDOUS SUFFERING FROM NTDs Gaston Sorgho, Fernando Lavadenz and Opope Oyaka Tshivuila Matala December 2018 KEY MESSAGES: • Eighteen Neglected Tropical Diseases (NTDs) and Malaria account together for 22% of the total burden of communicable diseases in 25 Francophone African Countries (FPACs). Public Disclosure Authorized • The cumulative impact of NTDs decreases the quality of life of households, slows economic growth and results in millions of dollars in lost economic productivity annually. For example, the World Bank (WB) estimates annual losses of US$33 million in Cameroon, US$13 million in Chad and US$9 million in Madagascar. • Of the 18 NTDs, 5 can be controlled by preventive chemotherapy (PC) through safe Mass Drug Administration (MDA). • In 2017, the WB launched the Deworming Africa Initiative (DAI), with the purpose of raising the profile of NTDs control and elimination efforts among endemic Sub-Saharan African (SSA) countries to eliminate NTDs as a public health threat. • DAI’s strategy seeks to reduce the burden of NTDs in 3 key population groups that mostly impact on human capital: young children (12-23 months), pregnant women, and school-age children (SAC) (5-14 years of age). To achieve this objective in a sustainable way, DAI supports Country efforts to strengthen the coordinated engagement of the health, education, water, sanitation and hygiene (WASH) and economic sectors with a national prevention and control strategy. • The WB's total annual investments in NTDs control have increased from US$3.3 million in 2013 to US$13.9 million in 2018. -
Better Together TNVR and Public Health APHA 11-13-18.Pdf
Better Together: TNVR and Public Health 11/13/2018 Presenter Disclosures Introduction Better Together TNVR and public health Peter J. Wolf and G. Robert Weedon • TNVR: trap-neuter-vaccinate-return G. Robert Weedon, DVM, MPH Clinical Assistant Professor and Service Head (Retired) Shelter Medicine, College of Veterinary Medicine University of Illinois • Emphasis on the “V” Peter J. Wolf, MS Research/Policy Analyst – Vaccination Best Friends Animal Society Have no relationships to disclose • Emphasizes the public health aspect of TNVR programs • Vaccinating against rabies as a means of protecting the health of the public Introduction TNVR TNVR • Why TNVR? • Why TNVR? – The only humane way to – More than half of impounded cats are euthanized deal with the problem of due to shelter crowding, shelter-acquired disease free-roaming (feral, or feral behavior animal welfareTNVR public health community) cats – TNVR, an alternative to shelter impoundment, – When properly applied, improves cat welfare and reduces the size of cat TNVR has been shown to colonies control/reduce populations rabies prevention of free-roaming cats Levy, J. K., Isaza, N. M., & Scott, K. C. (2014). Effect of high-impact targeted trap-neuter-return and adoption Levy, J. K., Isaza, N. M., & Scott, K. C. (2014). Effect of high-impact targeted trap-neuter-return and adoption of community cats on cat intake to a shelter. The Veterinary Journal, 201(3), 269–274. of community cats on cat intake to a shelter. The Veterinary Journal, 201(3), 269–274. TNVR TNVR TNVR • Why TNVR? • Why -
Equine Recommended Deworming Schedule
EQUINE FIELD SERVICE EQUINE RECOMMENDED DEWORMING SCHEDULE ADULT HORSE SCHEDULE n LOW SHEDDERS (<200 EPG – eggs per gram of manure) Fecal Egg Count performed prior to deworming in spring (ideally spring and fall) SPRING (March) – ivermectin (Equell®, Zimectrin®, Rotectin®, IverCare®), moxidectin (Quest®) FALL (October) – ivermectin w/praziquantel (Equimax®, Zimectrin Gold®) or moxidectin with praziquantel (Quest Plus®) n MODERATE SHEDDERS (200 – 500 EPG) Fecal Egg Count performed prior to deworming in spring (ideally spring and fall) SPRING (March) – Ivermectin (Equell®, Zimectrin®, Rotectin®, IverCare, etc), moxidectin (Quest®) or double-dose fenbendazole for 5 days (Panacur® PowerPak) LATE SUMMER (July) – pyrantel pamoate (Strongid paste®, TapeCare Plus®, etc), fenbendazole (Panacur®, Safe-Guard®) EARLY WINTER (November) – ivermectin w/praziquantel (Equimax®, Zimectrin Gold®) or moxidectin with praziquantel (Quest Plus®) n HIGH SHEDDERS (>500 EPG) Fecal Egg Count performed prior to deworming in spring and fall to monitor for signs of resistance SPRING (March) – ivermectin (Equell®, Zimectrin®, Rotectin®, IverCare®), moxidectin (Quest®) or double-dose of fenbendazole for 5 days (Panacur® PowerPak) SUMMER (June) – pyrantel pamoate (Strongid paste®, TapeCare Plus®), fenbendazole (Panacur, SafeGuard®) or Oxibendazole (Anthelcide®) FALL (September) – ivermectin w/ praziquantel (Equimax®, Zimectrin Gold®) or moxidectin with praziquantel (Quest Plus®) WINTER (December) – pyrantel pamoate (Strongid paste®, TapeCare Plus®), fenbendazole (Panacur®, -
General Horse Care MP501
MP501 General Horse Care DIVISION OF AGRICULTURE RESEARCH & EXTENSION University of Arkansas System University of Arkansas, United States Department of Agriculture, and County Governments Cooperating General Horse Care General Nutrition and Feeding Management ...............................................................................1 Determining the Amount to Feed ......................................................................................2 Selecting Grain and Hay ....................................................................................................3 Vaccinations ..................................................................................................................................5 Deworming ...................................................................................................................................6 Parasite Control via Manure Management .......................................................................7 Resisting Resistance .........................................................................................................7 Deworming Schedules ......................................................................................................7 Recognizing the Signs of Equine Colic ........................................................................................8 Preventing Barn Fires ...................................................................................................................9 Overview Mark Russell Instructor - Animal Science University -
Burden of Disease: What Is It and Why Is It Important for Safer Food?
Burden of disease: what is it and why is it important for safer food? What is ‘burden of disease’? Burden of disease is concept that was developed in the 1990s by the Harvard School of Public Health, the World Bank and the World Health Organization (WHO) to describe death and loss of health due to diseases, injuries and risk factors for all regions of the world.1 The burden of a particular disease or condition is estimated by adding together: • the number of years of life a person loses as a consequence of dying early because of the disease (called YLL, or Years of Life Lost); and • the number of years of life a person lives with disability caused by the disease (called YLD, or Years of Life lived with Disability). Adding together the Years of Life Lost and Years of Life lived with Disability gives a single-figure estimate of disease burden, called the Disability Adjusted Life Year (or DALY). One DALY represents the loss of one year of life lived in full health (see text box for more explanation and examples). Looking at burden of disease using DALYs can reveal surprises about a population’s health. For example, the Global Burden of Disease 2004 Update suggests that neuropsychiatric conditions are the most important causes of disability in all regions of the world, accounting for around 33% of all years lived with disability among adults aged 15 years and over, but only 2.2% of deaths.2 Therefore while psychiatric disorders are not traditionally regarded as having a major impact on the health of populations, this picture is completely altered when the burden of disease is estimated using DALYs. -
Defining Malaria Burden from Morbidity and Mortality Records, Self Treatment Practices and Serological Data in Magugu, Babati District, Northern Tanzania
Tanzania Journal of Health Research Volume 13, Number 2, April 2011 Defining malaria burden from morbidity and mortality records, self treatment practices and serological data in Magugu, Babati District, northern Tanzania CHARLES MWANZIVA1*, ALPHAXARD MANJURANO2, ERASTO MBUGI3, CLEMENT MWEYA4, HUMPHREY MKALI5, MAGGIE P. KIVUYO6, ALEX SANGA7, ARNOLD NDARO1, WILLIAM CHAMBO8, ABAS MKWIZU9, JOVIN KITAU1, REGINALD KAVISHE11, WIL DOLMANS10, JAFFU CHILONGOLA1 and FRANKLIN W. MOSHA1 1Kilimanjaro Clinical Research Institute, P. O. Box 2236, Moshi, Tanzania 2Joint Malaria Programme, Moshi, Tanzania 3Muhimbili University of Health and Allied Sciences, Dar es Salaam, Tanzania 4Tukuyu Medical Research Centre, Tukuyu, Tanzania 5Tabora Medical Research Centre, Tabora, Tanzania 6Ngongongare Medical Research Station, Usa River, Tanzania 7St. John University of Tanzania, Dodoma, Tanzania 8Amani Medical Research Centre, Muheza, Tanzania 9Magugu Health Centre, Babati, Manyara, Tanzania 10 Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands Abstract: Malaria morbidity and mortality data from clinical records provide essential information towards defining disease burden in the area and for planning control strategies, but should be augmented with data on transmission intensity and serological data as measures for exposure to malaria. The objective of this study was to estimate the malaria burden based on serological data and prevalence of malaria, and compare it with existing self-treatment practices in Magugu in Babati District of northern Tanzania. Prospectively, 470 individuals were selected for the study. Both microscopy and Rapid Diagnostic Test (RDT) were used for malaria diagnosis. Seroprevalence of antibodies to merozoite surface proteins (MSP- 119) and apical membrane antigen (AMA-1) was performed and the entomological inoculation rate (EIR) was estimated. To complement this information, retrospective data on treatment history, prescriptions by physicians and use of bed nets were collected. -
Deworming Recommendations for Georgia 2014 Horner & Nash, DVM, PC
Deworming Recommendations for Georgia 2014 Horner & Nash, DVM, PC In the past, veterinarians and parasitologists recommended a herd-based strategy which instructed owners to deworm every two months and to rotate between dewormers. Recent data, however, indicates that parasites are becoming resistant to our drugs and a more individualized approach is indicated based on bi-annual fecal egg counts. ADULT HORSES JANUARY 1. Submit a fecal sample from all horses to your veterinarian to ensure adequate control of parasites. DO THIS PRIOR TO TREATMENT! 2. Treat all horses with Moxidectin and Praziquantal (Quest Plus) Critical time of year to prevent strongyle egg shedding Moxidectin performs a larvidical deworming Cleans out bots and tapeworms ***Identify low, moderate or high egg shedders** Ensure to dose by your horse’s body weight **NOTE: It may be recommended that some extremely high egg shedders be dewormed with an Ivermectin first to decrease the adult worm load before the Moxidectin larvidical deworming is performed. This will be determined by your veterinarian from the fecal egg count results and previous history of deworming.** MARCH/APRIL 1. Submit a fecal sample to your veterinarian on moderate and high egg shedders 2. If treatment is needed then use Oxibendazole (Anthelcide) and Pyrantel Pamoate (Strongid). (If Ivermectin was used prior to Moxidectin/Praziquantal then no additional treatment is needed.) **NO further treatment is needed until September due to the heat and environment in Georgia** SEPTEMBER 1. Submit a fecal sample to your veterinarian to determine if your horse is a low, moderate or high egg shedder. DO THIS PRIOR TO TREATMENT! 2. -
Risk, Overdiagnosis and Ethical Justifications
Health Care Analysis (2019) 27:231–248 https://doi.org/10.1007/s10728-019-00369-7 ORIGINAL ARTICLE Risk, Overdiagnosis and Ethical Justifcations Wendy A. Rogers1 · Vikki A. Entwistle2 · Stacy M. Carter3 Published online: 4 May 2019 © The Author(s) 2019 Abstract Many healthcare practices expose people to risks of harmful outcomes. However, the major theories of moral philosophy struggle to assess whether, when and why it is ethically justifable to expose individuals to risks, as opposed to actually harming them. Sven Ove Hansson has proposed an approach to the ethical assessment of risk imposition that encourages attention to factors including questions of justice in the distribution of advantage and risk, people’s acceptance or otherwise of risks, and the scope individuals have to infuence the practices that generate risk. This paper investigates the ethical justifability of preventive healthcare practices that expose people to risks including overdiagnosis. We applied Hansson’s framework to three such practices: an ‘ideal’ breast screening service, a commercial personal genome testing service, and a guideline that lowers the diagnostic threshold for hypertension. The framework was challenging to apply, not least because healthcare has unclear boundaries and involves highly complex practices. Nonetheless, the framework encouraged attention to issues that would be widely recognised as morally pertinent. Our assessment supports the view that at least some preventive healthcare practices that impose risks including that of overdiagnosis are not ethically justifable. Further work is however needed to develop and/or test refned assessment criteria and guid‑ ance for applying them. Keywords Overdiagnosis · Risk · Uncertainty · Harm · Ethics · Risk evaluation * Wendy A. -
Diseases of Poverty and the 10/90 Gap Diseases of Poverty and the 10/90 Gap Diseases of Poverty and the 10/90 Gap
Diseases of poverty and the 10/90 gap Diseases of poverty and the 10/90 Gap Diseases of poverty and the 10/90 Gap Written by Philip Stevens, Director of Health Projects, International Policy Network November 2004 International Policy Network Third Floor, Bedford Chambers The Piazza London WC2E 8HA UK t : +4420 7836 0750 f: +4420 7836 0756 e: [email protected] w : www.policynetwork.net © International Policy Network 2004 Designed and typeset in Latin 725 by MacGuru Ltd [email protected] Cover design by Sarah Hyndman Printed in Great Britain by Hanway Print Centre 102–106 Essex Road Islington N1 8LU All rights reserved. Without limiting the rights under copyright reserved above, no part of this publication may be reproduced, stored or introduced into a retrieval system, or transmitted, in any form or by any means (electronic, mechanical, photocopying, recording or otherwise) without the prior written permission of both the copyright owner and the publisher of this book. Diseases of poverty and the 10/90 Gap Introduction: What is the 10/90 Gap? Figure 1 Number of daily deaths from diseases7 Activists claim that only 10 per cent of global health research is devoted to conditions that account for 90 Respiratory 10,814 per cent of the global disease burden – the so-called infections 1 ‘10/90 Gap’. They argue that virtually all diseases HIV/ 7,852 AIDS prevalent in low income countries are ‘neglected’ Diarrhoeal 5,482 and that the pharmaceutical industry has invested diseases almost nothing in research and development (R&D) Tuberculosis 4,504 for these diseases. -
Human Resource for Health Migration: an Analysis from the Perspective of Utilitarianism Rupesh Gautam University of Southern Denmark, [email protected]
Online Journal of Health Ethics Volume 12 | Issue 1 Article 5 Human Resource for Health Migration: An Analysis from the Perspective of Utilitarianism Rupesh Gautam University of Southern Denmark, [email protected] Pawan Acharya University of Southern Denmark, [email protected] Follow this and additional works at: http://aquila.usm.edu/ojhe Recommended Citation Gautam, R., & Acharya, P. (2016). Human Resource for Health Migration: An Analysis from the Perspective of Utilitarianism. Online Journal of Health Ethics, 12(1). http://dx.doi.org/10.18785/ ojhe.1201.05 This Article is brought to you for free and open access by The Aquila Digital Community. It has been accepted for inclusion in Online Journal of Health Ethics by an authorized administrator of The Aquila Digital Community. For more information, please contact [email protected]. Human Resource for Health Migration: An Analysis from the Perspective of Utilitarianism Introduction Medical brain drain or health-worker migration is a part of what has been labeled a global health workforce crisis and is characterized by the migration of trained and skilled health workers (doctors, nurses, and midwives) from low-income countries to high-income countries. It leads to loss in human capital for the developing countries, uneven distribution of those professionals between the affluent and poor countries and more severe suffering for the latter, due to the heavy disease burden (Kollar & Buyx, 2013; WHO, 2006). According to an estimate by WHO, a healthcare system is considered unable to deliver essential health services if it operates with fewer than 23 health workers (doctors, nurses, or midwives) for every 10,000 members of its population (WHO, 2006). -
Conducting a School Deworming Day: a Manual for Teachers
Conducting a school deworming day A manual for teachers WHO Library Cataloguing-in-Publication Data Conducting a school deworming day: a manual for teachers. 1.Parasitic diseases – prevention and control. 2.Helminths. 3.Child. 4.Schools. 5.Teaching materials. I.World Health Organization. ,6%1 1/0FODVVLÀFDWLRQ:& © World Health Organization 2013 $OOULJKWVUHVHUYHG3XEOLFDWLRQVRIWKH:RUOG+HDOWK2UJDQL]DWLRQDUHDYDLODEOHRQWKH:+2ZHEVLWH ZZZZKRLQW RUFDQEHSXUFKDVHGIURP:+23UHVV :RUOG+HDOWK2UJDQL]DWLRQ$YHQXH$SSLD*HQHYD6ZLW]HUODQG WHOID[HPDLOERRNRUGHUV#ZKRLQW 5HTXHVWVIRUSHUPLVVLRQWRUHSURGXFHRUWUDQVODWH:+2SXEOLFDWLRQV²ZKHWKHUIRUVDOHRUIRUQRQFRPPHUFLDOGLVWULEXWLRQ²VKRXOGEHDGGUHVVHGWR:+2 3UHVVWKURXJKWKH:+2ZHEVLWH ZZZZKRLQWDERXWOLFHQVLQJFRS\ULJKWBIRUPHQLQGH[KWPO 7KHGHVLJQDWLRQVHPSOR\HGDQGWKHSUHVHQWDWLRQRIWKHPDWHULDOLQWKLVSXEOLFDWLRQGRQRWLPSO\WKHH[SUHVVLRQRIDQ\RSLQLRQZKDWVRHYHURQWKHSDUWRIWKH :RUOG+HDOWK2UJDQL]DWLRQFRQFHUQLQJWKHOHJDOVWDWXVRIDQ\FRXQWU\WHUULWRU\FLW\RUDUHDRURILWVDXWKRULWLHVRUFRQFHUQLQJWKHGHOLPLWDWLRQRILWVIURQWLHUV RUERXQGDULHV'RWWHGOLQHVRQPDSVUHSUHVHQWDSSUR[LPDWHERUGHUOLQHVIRUZKLFKWKHUHPD\QRW\HWEHIXOODJUHHPHQW 7KHPHQWLRQRIVSHFLÀFFRPSDQLHVRURIFHUWDLQPDQXIDFWXUHUV·SURGXFWVGRHVQRWLPSO\WKDWWKH\DUHHQGRUVHGRUUHFRPPHQGHGE\WKH:RUOG+HDOWK 2UJDQL]DWLRQLQSUHIHUHQFHWRRWKHUVRIDVLPLODUQDWXUHWKDWDUHQRWPHQWLRQHG(UURUVDQGRPLVVLRQVH[FHSWHGWKHQDPHVRISURSULHWDU\SURGXFWVDUH distinguished by initial capital letters. $OOUHDVRQDEOHSUHFDXWLRQVKDYHEHHQWDNHQE\WKH:RUOG+HDOWK2UJDQL]DWLRQWRYHULI\WKHLQIRUPDWLRQFRQWDLQHGLQWKLVSXEOLFDWLRQ+RZHYHUWKHSXEOLVKHG PDWHULDOLVEHLQJGLVWULEXWHGZLWKRXWZDUUDQW\RIDQ\NLQGHLWKHUH[SUHVVHGRULPSOLHG7KHUHVSRQVLELOLW\IRUWKHLQWHUSUHWDWLRQDQGXVHRIWKHPDWHULDOOLHVZLWK -
Why Neglected Tropical Diseases Matter in Reducing Poverty 1.42 MB
July 2013 Working Paper 03 Why neglected tropical diseases matter in reducing poverty Fiona Samuels and Romina Rodríguez Pose • Neglected tropical diseases (NTDs) have a direct impact on the achievement This and other Development of the Millennium Development Goals (MDGs). Without addressing these Progress materials are available at Key diseases, the broader aim of poverty alleviation is unlikely to be achieved. developmentprogress.org messages • Straightforward and highly cost-effective strategies are available to control Development Progress is an ODI project and eventually eradicate or eliminate NTDs. that aims to measure, understand and communicate where and how progress • Success in controlling, eliminating or eradicating NTDs depends on has been made in development. partnerships between multiple constituencies that enable countries to adapt international guidelines to local contexts, integrate NTD programmes into ODI is the UK’s leading independent think tank on international development health systems and engage communities in implementation. and humanitarian issues. Further ODI materials are available at odi.org.uk Introduction indicators specific to them (Molyneux, 2008). While neglected tropical diseases (NTDs) One possible explanation for have been recognised for centuries – international disinterest is that NTDs indeed as ‘biblical plagues’ – NTDs have, almost exclusively affect the developing as the name implies, remained below the world (though this is also true for malaria) radar of most international and national and are not likely to spread far beyond; policy-makers. indeed, many NTDs have disappeared This relative neglect can be seen in completely in the developed world due examining the Millennium Development to improved hygiene and sanitation Goal (MDG) framework: while NTDs standards.